These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12706655)
41. Chemistry strategies in early drug discovery: an overview of recent trends. Colombo M; Peretto I Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762 [TBL] [Abstract][Full Text] [Related]
42. SYNOPSIS: SYNthesize and OPtimize System in Silico. Vinkers HM; de Jonge MR; Daeyaert FF; Heeres J; Koymans LM; van Lenthe JH; Lewi PJ; Timmerman H; Van Aken K; Janssen PA J Med Chem; 2003 Jun; 46(13):2765-73. PubMed ID: 12801239 [TBL] [Abstract][Full Text] [Related]
43. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities. Couvreur P; Barguer D; Crommelin DJ; DuchĂȘne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E; Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539 [No Abstract] [Full Text] [Related]
44. Automated medicinal chemistry. Koppitz M; Eis K Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909 [TBL] [Abstract][Full Text] [Related]
45. Natural product drug discovery: the times have never been better. Galm U; Shen B Chem Biol; 2007 Oct; 14(10):1098-104. PubMed ID: 17961822 [TBL] [Abstract][Full Text] [Related]
46. Chemical library synthesis using convergent approaches. Beeler AB; Schaus SE; Porco JA Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329 [TBL] [Abstract][Full Text] [Related]
47. Natural products and combinatorial chemistry: back to the future. Ortholand JY; Ganesan A Curr Opin Chem Biol; 2004 Jun; 8(3):271-80. PubMed ID: 15183325 [TBL] [Abstract][Full Text] [Related]
48. Chemical genomics: a systematic approach in biological research and drug discovery. Zheng XF; Chan TF Curr Issues Mol Biol; 2002 Apr; 4(2):33-43. PubMed ID: 11931568 [TBL] [Abstract][Full Text] [Related]
52. Chemical substructures that enrich for biological activity. Klekota J; Roth FP Bioinformatics; 2008 Nov; 24(21):2518-25. PubMed ID: 18784118 [TBL] [Abstract][Full Text] [Related]
53. Drug industry looks to the lab instead of rainforest and reef. Service RF Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712 [No Abstract] [Full Text] [Related]
54. Race for molecular summits. Service RF Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711 [No Abstract] [Full Text] [Related]
56. Aligning pharmaceutical innovation with medical need. Nathan C Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145 [No Abstract] [Full Text] [Related]
57. Process technologies for purity enhancement of large discovery libraries. Pottorf RS; Player MR Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438 [TBL] [Abstract][Full Text] [Related]
58. The importance of synthetic chemistry in the pharmaceutical industry. Campos KR; Coleman PJ; Alvarez JC; Dreher SD; Garbaccio RM; Terrett NK; Tillyer RD; Truppo MD; Parmee ER Science; 2019 Jan; 363(6424):. PubMed ID: 30655413 [TBL] [Abstract][Full Text] [Related]
59. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. Gordon EM; Barrett RW; Dower WJ; Fodor SP; Gallop MA J Med Chem; 1994 May; 37(10):1385-401. PubMed ID: 8182695 [No Abstract] [Full Text] [Related]
60. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. Feher M; Schmidt JM J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]